INTRODUCTION {#S1}
============

The progression through the cell cycle is exquisitely regulated at multiple levels. Genes are actively transcribed and repressed, and proteins are modified and/or degraded in a series of highly ordered processes. At the transcriptional level, E2F transcription factors represent critical regulators of cell-cycle progression. These proteins are clustered into transcriptional activators (E2F1, E2F2, and E2F3a) or repressors (E2F3b, E2F4--8) and are responsible for the regulation of the expression of hundreds of cell-cycle-related genes ([@R14]). E2F transcription factors are regulated primarily by the pocket protein family, which includes RB1 and the related p107 and p130 proteins. During the G~1~ phase of the cell cycle, RB1 interacts with activating E2Fs and inhibits their ability to activate transcription. Additionally, p107 and p130 interact with E2F repressors to actively suppress transcription of cell-cycle genes in quiescence and early phases of the cell cycle ([@R6]; [@R15]; [@R20]; [@R31]; [@R58]). The molecular bases underlying the ability of p107/p130 to modulate E2F target gene expression was recently elucidated in part with the identification of the highly conserved DREAM (DP, RB-like, E2F, and MuvB) complex ([@R32]; [@R38]; [@R39]).

The mammalian DREAM complex is composed of p130 or p107, DP1 or DP2, and E2F4 or E2F5, and the MuvB core including LIN9, LIN37, LIN52, LIN54, and RBBP4 or RBBP7 ([@R44]). The DREAM complex localizes to the promoters of hundreds of cell-cycle-regulated genes and contributes to their repression during quiescence ([@R32]). Depletion studies of various members of the DREAM complex have been confounding. While the knockdown of individual subunits of DREAM leads to a transcriptional derepression of its targets, the resulting upregulations are only modest ([@R32]). In addition, this de-repression event is not sufficient to cause cell-cycle re-entry ([@R32]). However, the mutation of S28 on the MuvB subunit LIN52, a crucial phosphorylation site for the assembly of the DREAM complex, rendered cells refractory to oncogenic Rasinduced senescence ([@R33]). These findings are in agreement with previously shown functional compensation by all three pocket proteins for cell-cycle exit ([@R10]; [@R46]). Intriguingly, there was no evidence of any chromatin-modifying proteins in the initial mass-spectrometry studies identifying the proteins associated with DREAM ([@R32]). A recent study, however, indicated that genetic inactivation of the DREAM component Lin37 leads to a potent de-repression of cell-cycle gene transcription in G~0~/G~1~ ([@R34]). As Lin37 itself does not harbor enzymatic activity, it likely recruits transcriptional co-repressors that remain to be identified.

Among the better-studied transcriptional co-repressor complexes, the Sin3/HDAC complex is characterized by the presence of the highly conserved and ubiquitously expressed Sin3 protein. Containing no DNA binding domain or enzymatic activity of its own, Sin3 has been established as a flexible scaffold protein able to assemble large, modular, repressive complex(es) ([@R51]). Sin3 owes its repressive activity at least in part to its direct interaction with HDAC1 and HDAC2, and in some instances, with KDM5A, and is recruited to target loci through its association with sequence-specific transcription factors ([@R5]; [@R25]; [@R26]; [@R27]; [@R28]; [@R35]; [@R59], [@R60]; [@R61]). In mammals, the Sin3 family consists of two proteins, Sin3A and Sin3B, with both redundant and non-redundant functions. While *Sin3a*-deleted murine cells exhibit severe proliferation defects and massive apoptosis, *Sin3b*-deleted primary fibroblasts proliferate normally ([@R11]; [@R12]). Interestingly, *Sin3b*-deleted cells are refractory to oncogene-induced senescence and, in some settings, exhibit altered terminal differentiation ([@R8]; [@R11]; [@R12]; [@R21]; [@R42]). In addition, it has been shown that p107 and p130 specifically recruit the Sin3B/HDAC complex to promote chromatin compaction and subsequent transcriptional repression ([@R3]; [@R12]; [@R40]).

Here, we report that the Sin3B/HDAC complex robustly interacts with the DREAM complex in a cell-cycle-dependent manner. We demonstrate that Sin3B specifically associates with the DREAM complex during quiescence and early G~1~, and retains its ability to interact with the MuvB core throughout the cell cycle. Analysis of the transcriptome revealed that deletion of Sin3B resulted in a global de-repression of established DREAM target genes. These target loci encode for cell-cycle-related proteins and are bound by Sin3B at their promoter regions. Human cancer cells lacking Sin3B were, however, able to enter quiescence normally and progress through the cell cycle with normal kinetics. Strikingly, ectopic expression of the APC/C^CDH1^ inhibitor EMI1 was sufficient to promote cell-cycle re-entry of Sin3B deleted cells under serum-deprived conditions, while the Sin3B wild-type cells remained quiescent. This study sheds light on the ability of DREAM to recruit the chromatin-modifying Sin3B/HDAC complex to repress its target genes. This also points to the functional cooperation between APC/C^CDH1^ and DREAM in the regulation of G~1~- to S-phase cell-cycle progression.

RESULTS {#S2}
=======

Sin3B Interacts with the DREAM and the MMB Complexes {#S3}
----------------------------------------------------

To investigate the molecular mechanisms underlying Sin3B's impact on cellular proliferation, stable cell lines were generated to express FLAG-tagged Sin3B in the absence of the corresponding endogenous protein. Specifically, immortalized Sin3B-null mouse embryonic fibroblasts were infected with either a retrovirus encoding C-terminal FLAG-tagged Sin3B or with the corresponding empty retrovirus. Sin3B-associated polypeptides were affinity purified using an anti-FLAG antibody and identified by tandem mass spectrometry. Consistent with previous reports, we identified several members of the canonical Sin3-HDAC complex, which include the following: Sin3A, HDAC1, HDAC2, RBBP7, SAP130, ARID4B, ING1, ING2, SUDS3, SAP30, SAP30L, BRMS1L, and BRMS1 ([@R4]) ([Figure 1A](#F1){ref-type="fig"}). Additionally, several members of a recently characterized smaller Sin3B complex were identified as well ([@R22]; [@R28]). These proteins include the following: PHF12, KDM5A, EMSY, and MORF4L1. Strikingly, Sin3B immunoprecipitates contained detectable peptides corresponding to all members of the mammalian DREAM complex (DP1, p130, p107, E2F4, RBBP4, LIN9, LIN37, and LIN54), except for LIN52 ([Figure 1A](#F1){ref-type="fig"}). The interaction between Sin3B and the DREAM component LIN9 was confirmed by immunoprecipitation in T98G cells, following transient co-expression of the two proteins ([Figure 1B](#F1){ref-type="fig"}). Additionally, ectopically expressed Sin3B was able to associated with endogenous DREAM components LIN9, LIN37, p107, and p130 ([Figure 1C](#F1){ref-type="fig"}). The MuvB complex dissociates from DP1-p130-E2F4 as cells progress through the cell cycle, to form a stable complex with BMYB in G~1~/S called MMB, and then an independent complex with FOXM1 in S phase ([@R45]). Interestingly, BMYB was detected as a Sin3B-associated protein ([Figure 1A](#F1){ref-type="fig"}), and the corresponding interaction was confirmed by co-immunoprecipitation (co-IP) in Sin3B-transfected T98G cells ([Figure 1C](#F1){ref-type="fig"}). In contrast, we were unable to detect FOXM1 in the Sin3B^FLAG^ immunoprecipitates by mass spectrometry, or detect an interaction between Sin3B and FOXM1 upon co-expression in 293T cells, while we successfully detected components of the DREAM and MMB complexes in this assay ([Figure S1](#SD1){ref-type="supplementary-material"}). Taken together, these results indicate that Sin3B interacts with the DREAM complex, as well as with the MMB complex, but likely not with the MuvB-FOXM1 complex.

The Sin3B/DREAM Interaction Is Established in Quiescent Cells {#S4}
-------------------------------------------------------------

The human DREAM complex has been previously characterized using the human glioblastoma cell line T98G ([@R32]). To further validate our findings, we demonstrated that endogenous LIN37, an integral member of the MuvB complex, associates with both endogenous and exogenous Sin3B in asynchronous human T98G cells ([Figure 2A](#F2){ref-type="fig"}). We also confirmed this interaction using mouse NIH 3T3 cells ([Figure 2A](#F2){ref-type="fig"}). Finally, immunoprecipitation with an anti-Sin3B antibody revealed an association with additional members of the DREAM complex, namely LIN9, LIN37, and p130 at the endogenous level, thus confirming a specific and robust interaction between Sin3B and the DREAM complex ([Figure 2B](#F2){ref-type="fig"}).

As mentioned above, the mammalian DREAM complex is present in G~0~/G~1~ but dissociates in late G~1~, releasing the MuvB core from p130 and E2F4. Since we performed our initial analysis in asynchronously cycling cells, we tested the interaction of Sin3B with DREAM complex components in synchronized cells. T98G cells were rendered quiescent by serum deprivation for 72 hr, prior to immunoprecipitation. As expected, Sin3B robustly associated with the MuvB components LIN9 and LIN37 in both the cycling and serum-starved cells, whereas the DREAM-specific p130 interacted more strongly in quiescent cells ([Figure 2B](#F2){ref-type="fig"}). To investigate the interaction between Sin3B and the DREAM complex components as cells progress through the cell cycle, quiescent T98G cells were released into serum-containing medium, and Sin3B immunoprecipitations were performed at various time points. As shown in [Figure 2C](#F2){ref-type="fig"}, Sin3B associates with p130 in G~0~ and G~1~, but not at later cell-cycle phases, consistent with the well-established dissociation of p130 from MuvB past the mid-G~1~ point caused by increased activity of CDK4/6 and CDK2 ([@R23]; [@R32]; [@R37]; [@R54]). Strikingly, the interaction between Sin3B and the MuvB core components LIN9 and LIN37 is retained throughout G~1~ and S phases. Consistent with the upregulation of LIN9 during cell-cycle progression, the association between Sin3B and LIN9 increases as cells progressed through the cell cycle ([Figure 2C](#F2){ref-type="fig"}). Since MuvB interacts with p130 and BMYB in different phases of the cell cycle, our results suggest that Sin3B interacts with the MuvB core components independently of p130 or BMYB. To confirm the hypothesis that Sin3B interacts with the MuvB core components independently of the Rb-related pocket proteins, we tested the ability of Sin3B to associate with LIN9 and LIN37 in immortalized mouse embryonic fibroblasts (MEFs) genetically inactivated for Rb, p107, and p130 (TKO \[triple knockout\] \[[@R10]\]). As shown in [Figure 2D](#F2){ref-type="fig"}, the interaction between Sin3B and MuvB core components was not affected by the absence of Rb-related pocket proteins.

DREAM Interacts with Sin3B through the PAH3/HID {#S5}
-----------------------------------------------

Sin3B contains several well-characterized domains responsible for its interaction with different partners such as HDAC1 ([@R51]). To identify Sin3B domains responsible for its interaction with MuvB, we generated truncation mutants of Sin3B ([Figure S2A](#SD1){ref-type="supplementary-material"}). We then performed immunoprecipitations using these mutants and probed for the association with LIN9. As shown in [Figure S2B](#SD1){ref-type="supplementary-material"}, mutants containing the PAH1 and PAH2 domains, or the HCR domain only, were unable to interact with LIN9. However, all Sin3B mutants containing the PAH3/HID domains were able to associate with LIN9. Taken together, these results suggest that DREAM interacts with Sin3B through the PAH3/HID, independently of the Sin3B-HDAC1 interaction.

Sin3B Is Required for the Transcriptional Repression of DREAM Target Genes {#S6}
--------------------------------------------------------------------------

Previous studies have demonstrated that an integral DREAM complex is required for the repression of more than 800 cell-cycle-related genes ([@R44]). Based on the robust interaction detected between Sin3B and the DREAM complex, and the lack of repressive activity within the known components of the DREAM complex, we hypothesized that Sin3B tethers the enzymatic activities required for DREAM targets' repression. To test this, Sin3B was genetically deleted in T98G cells via CRISPR/Cas9, resulting in the isolation of knockout clones from two independent Sin3B-targeting sgRNA pairs, and wild-type clones using the same guide pairs ([Figure 3A](#F3){ref-type="fig"}). Sin3B-deleted T98G cells were then synchronized by serum starvation and released into serum-containing medium. Protein expression levels of specific DREAM targets were evaluated at different stages of the cell cycle. Notably, Sin3B inactivation resulted in the premature upregulation of cyclin A2 (encoded by the DREAM target gene *CCNA2*) in Sin3B-deleted cells in G~0~, compared to their wild-type counterparts ([Figure 3A](#F3){ref-type="fig"}). Importantly, we confirmed these results using a short hairpin RNA (shRNA) construct to knock down Sin3B expression ([Figure S3](#SD1){ref-type="supplementary-material"}). Indeed, cyclin A2 and cyclin F were found upregulated in quiescent Sin3B-depleted cells, and their levels continued to increase as the cells progressed through the cell cycle after released into serum-containing medium, indicating that Sin3B likely restricts the expression of these proteins at least during early phases of the cell cycle.

To gain insight into the repressive function of Sin3B on a genome-wide scale, the Sin3B-dependent transcriptome was investigated by RNA sequencing using two wild-type and two Sin3B-deleted T98G cell lines at different time points after release in serum-containing medium corresponding to G~0~, G~1~, and G~1~/S phases ([Figure 3B](#F3){ref-type="fig"}). Differential expression analysis identified 429 genes de-repressed specifically in Sin3B-deleted cells in G~0~. Interestingly, fewer transcripts exhibited Sin3B-dependent de-repression in G~1~ or S phase, compared to the number of genes repressed by Sin3B in G~0~ ([Figure 3B](#F3){ref-type="fig"}). Gene ontology (GO) analysis and gene set enrichment analysis (GSEA) of the genes significantly altered upon Sin3B inactivation in G~0~ reveal a significant enrichment in cell-cycle- and DNA synthesis-related processes ([Figure S4](#SD1){ref-type="supplementary-material"}) [@R9]; [@R29]). Using the DREAM target network database ([@R18]), we determined that, out of the 429 genes specifically de-repressed in the absence of Sin3B in G~0~, 140 genes (33%) were previously established as DREAM targets. Chromatin immunoprecipitation enrichment analysis (ChEA) and transcription factor binding analyses on these genes indicate a significant enrichment for E2F4/7, E2F1, and Sin3A potential binding sites in the promoter regions of these loci ([@R9]; [@R29]) ([Figure S4](#SD1){ref-type="supplementary-material"}). Notably, Sin3B directly binds 108 (77%) of these 140 DREAM targets in other cellular systems ([@R60]). We confirmed the Sin3B deletion-induced derepression of several E2F/DREAM targets using qRT-PCR in independent Sin3B-null cell lines ([Figure 3C](#F3){ref-type="fig"}). Importantly, ectopic expression of Sin3B was sufficient to rescue the transcriptional repression of these DREAM targets in Sin3B-null quiescent cells ([Figure 3D](#F3){ref-type="fig"}). Finally, we verified the enrichment of Sin3B on several DREAM target promoters regions in quiescent cells using chromatin immunoprecipitation (ChIP) ([Figure 3E](#F3){ref-type="fig"}). In these experiments, genetic inactivation of Sin3B did not significantly alter the recruitment of the DREAM complex to these DNA regions, as evidenced by similar E2F4 ChIP-qPCR signals in quiescent Sin3B-null and control cells ([Figure 3E](#F3){ref-type="fig"}). However, histone acetylation was significantly increased at DREAM target loci upon loss of Sin3B, consistent with the model that Sin3B tethers HDAC activity to the DREAM targets in quiescence. Of note, a potent HDAC activity was found associated with Sin3B throughout cell-cycle progression (data not shown), suggesting that the repressive activity of the complex is dictated by its recruitment to target loci rather than the modulation of its activity throughout cell-cycle progression. Taken together, these results strongly suggest that Sin3B mediates the repressive function of DREAM in order to silence the expression of cell-cycle-regulated genes in quiescence, through its ability to tether histone modifiers to chromatin.

Sin3B Is Dispensable for Entry into Quiescence in Human Cells {#S7}
-------------------------------------------------------------

Having established a role for Sin3B in the transcriptional repression of DREAM target genes in quiescence, we investigated the functional relevance of this observation on cell-cycle progression. To induce quiescence, Sin3B-deleted T98G cells and the parental cells were serum-starved for 72 hr ([Figure 4A](#F4){ref-type="fig"}). At this time point, no apparent difference in KI67 positivity was observed between Sin3B wild-type and Sin3B-null cells ([Figures 4B and 4C](#F4){ref-type="fig"}). Consistently, bromodeoxyuridine (BrdU) incorporation, indicative of replication, was only marginally increased in Sin3B-null quiescent cells versus Sin3B wild-type quiescent cells, but these differences failed to reach significance ([Figures 4D--4F](#F4){ref-type="fig"}). Taken together, these results indicate that loss of Sin3B alone appears to be insufficient to disrupt entry into quiescence in human cells.

We also documented the effect of Sin3B deletion on the kinetics of cell-cycle re-entry. Serum-starved Sin3B-deleted cells were released into serum-containing medium, and cells were collected and analyzed at T0 (G~0~), T10 (G~1~), and T18 (G~1~/S). Propidium iodide staining failed to reveal any significant differences in DNA content between Sin3B wild-type and Sin3B-null cells at any of these time points ([Figure 4G](#F4){ref-type="fig"}). We further validated this finding using the FUCCI cell-cycle probes system ([@R47]), whereby we determined that cells lacking Sin3B progress through the cell cycle following release into serum-containing medium at the rates comparable to that of Sin3B wild-type cells ([Figure 4H](#F4){ref-type="fig"}). These data suggest that Sin3B is dispensable for entry into quiescence and subsequent re-entry into the cell cycle, consistent with previously reported phenotypes of cells depleted of different components of the DREAM complex ([@R19]; [@R34]).

Loss of Sin3B Primes Cells for Entry into the Cell Cycle {#S8}
--------------------------------------------------------

While the genetic inactivation of Sin3B results in the de-repression of cell-cycle-related DREAM targets during quiescence, it bears no effect on the ability of cells to enter into quiescence under serum-deprived conditions. Therefore, we hypothesized that, in the absence of mitogenic signals, Sin3B-deleted cells do not progress to S phase because of their inability to bypass the G~1~/S restriction point. To test this, we inhibited APC/C^CDH1^, an E3 ubiquitin ligase that contributes to the maintenance of quiescence by promoting the degradation of positive cell-cycle regulators such as cyclin A2. To this end, EMI1, a negative regulator of APC/C^CDH1^ ([@R41]), was ectopically expressed under control of tet-inducible promoter in either wild-type or Sin3B-null cells expressing the FUCCI cell-cycle probes ([Figure 5A](#F5){ref-type="fig"}). Serum-starved cells were treated with doxycycline to induce EMI1 expression, and cell-cycle progression was assessed via FUCCI probe positivity over 48 hr. Cells were kept in serum-free medium throughout the experiment. Intriguingly, cyclin A2 levels remained low in the wild-type cells regardless of EMI1 levels but increased noticeably in Sin3B knockout cells following doxycycline administration, correlating with the increased expression of EMI1 ([Figure 5A](#F5){ref-type="fig"}). Parental cells exhibited marginal GFP positivity prior to EMI1 induction, which only slightly increased with EMI1 expression (10%, 14%, and 19% GFP positive at 0 hr \[T0\], 24 hr \[T24\], and 48 hr \[T48\] after doxycycline administration, respectively). Strikingly, Sin3B knockout cells exhibited a dramatic increase in GFP-positive cells following EMI1 induction (11%--15% at T0, 30%--36% at T24, and 51%--53% at T48) ([Figure 5B](#F5){ref-type="fig"}). As increased GFP expression in this system could reflect the increased stability of the FUCCI reporter upon APC/C inactivation, independent of cell-cycle progression, we also assessed S-phase entry using BrdU incorporation. This approach confirmed that serumstarved Sin3B knockout cells expressing EMI1 entered S phase at a higher rate than their wild-type counterparts ([Figure S5](#SD1){ref-type="supplementary-material"}). Notably, a slight increase in the ability of Sin3B^−/−^ cells to exit quiescent was noted prior to doxycycline administration, likely reflecting the leakiness of the inducible Emi-1 expression system. Finally, these results were corroborated by monitoring the effect of proTAME, a potent APC/C^CDH1^ inhibitor. While proTAME administration did not affect the ability of wild-type cells to remain in G~0~ in serum-deprived conditions, the addition of proTAME led to a noticeable and significant entry into the cell cycle of Sin3B-deleted cells ([Figure 5C](#F5){ref-type="fig"}). Together, these results indicate that, while insufficient to promote cell-cycle entry, genetic inactivation of Sin3B primes quiescent cells for cell-cycle progression through the de-repression of cell-cycle-related DREAM target genes.

DISCUSSION {#S9}
==========

We demonstrate here that the scaffold protein Sin3B associates with the DREAM complex, a master regulator of transcriptional control of the cell-cycle genes in quiescence. Our study further indicates that Sin3B carries the long-sought-after repressive activity associated with the DREAM complex, and its inactivation results in the hyper-acetylation of DREAM target promoter regions and transcriptional de-repression of the corresponding genes. Thus, this study establishes the functional relevance of the interaction between Sin3B and the DREAM complex in quiescence. While a prior study had suggested an interaction between DREAM and Sin3B-HDAC1, it did not test the functional relevance of this interaction ([@R48]). Our mass spectrometry results also demonstrate that Sin3B interacts with BMYB. The MuvB core has been shown to exhibit mutual exclusivity between its interaction with p130 and BMYB during the cell-cycle progression in mammalian cells ([@R32]; [@R39]; [@R45]; [@R50]). Upon entry into G~1~/S, p130 dissociates from the MuvB core and is replaced by BMYB to form the BMYB/MuvB (MMB) complex. This complex is recruited to a subset of E2F targets, primarily late S-phase genes, and its subsequent phosphorylation by cyclin A/CDK2 further results in the recruitment of the transcriptional activator FOXM1 ([@R45]; [@R49]). Whether this MMB complex harbors a transcriptional repressive activity, or it merely serves as an intermediate complex between the repressive DREAM and the activating FOXM1/MuvB, remains unclear. Our demonstration that Sin3B interacts with BMYB suggests the former possibility.

The MuvB complex was first identified in *C. elegans* ([@R24]). Additional screens to detect genes that antagonize Ras signaling through the *SynMuv* pathway in the *C. elegans* vulva identified several components of the Sin3 complex, namely *hda1* and *lin-53* (homologs of HDAC1/2 and RbAP46/48, respectively) ([@R52]). However, multiple components of the HDAC-containing complex NuRD were also identified in this pathway ([@R52]), pointing to the involvement of this complex, rather than the *C. elegans Sin3* complex. It is, however, important to note that *C. elegans* only has one Sin3 protein, suggesting that a specific Sin3B-related complex may have appeared later in evolution.

Additionally, we have shown that the interaction between DREAM and Sin3B requires an intact PAH3/HID. This result is consistent with the previous demonstration that Sin3 proteins interact with the pocket proteins through adaptors such as ARID4B and SAP30 through PAH3 ([@R30]). Importantly, our observation that Sin3B interacts with both p130 and BMYB implies that this interaction is mediated by the MuvB core that is shared between both the DREAM and MMB complexes, consistent with the demonstration that Sin3B interacts with MuvB components independently of the Rb-related pocket proteins.

RNA sequencing analysis revealed that Sin3B represses the expression of 140 DREAM target genes in quiescence. The actual number of annotated DREAM targets ranges between approximately 400 and 800 genes ([@R32]), raising questions about the generality of Sin3B requirement in DREAM repression. The discrepancy between the number of genes derepressed in Sin3B knockout cells and the number of established DREAM targets may stem from the stringency level used in our statistical analysis. Indeed, various DREAM target genes that did not meet the false discovery rate (FDR) cutoff were found to be de-repressed in the two Sin3B knockout cell lines, but at variable levels. Alternatively, there may be some functional compensation by Sin3A in the absence of Sin3B. Indeed, our mass spectrometry analysis showed that Sin3A was among the top interactors of Sin3B ([Figure 1A](#F1){ref-type="fig"}). This observation underscores the need to better define how DREAM and Sin3B are interacting, and whether Sin3A and DREAM can interact independently of Sin3B. Furthermore, identification of an adaptor protein that serves as a potential bridge between the Sin3B and DREAM complexes may further aid in the elucidation of these interactions. Indeed, a recent study showed that LIN37 is essential for the repressive activity associated with the DREAM complex ([@R34]), suggesting the possibility that LIN37 could tether Sin3B to the DREAM target promoters.

Consistent with the absence of cell-cycle re-entry observed in cells inactivated for different components of the DREAM complex, we demonstrate here that Sin3B inactivation is not sufficient to allow quiescent cells to resume proliferation. However, we have recently demonstrated that hematopoietic stem cells genetically inactivated for Sin3B exhibit a modest defect in their ability to remain quiescent ([@R8]). These observations suggest that, under specific conditions, Sin3B inactivation allows quiescent cells to resume proliferation. A recent study revealed that simultaneous deletion of LIN37 and pRb allows quiescent cells to enter S phase ([@R34]). It is thus likely that dual inactivation of Sin3B and Rb would similarly result in the inability of cells to remain quiescent in low-serum conditions. Here, we show that Sin3B-null cells are sensitive to EMI1-induced cell-cycle re-entry, while Sin3B-expressing cells are not. Therefore, we hypothesize that an APC/C^CDH1^ -dependent G~1~/S restriction point precludes cycling of quiescent Sin3B-deleted cells. Interestingly, a genetic screen in *C. elegans* identified *fzr-1*, the homolog of Cdh1, as a gene whose mutation is synthetic lethal with mutations in *lin-35*, the homolog of Rb and the related Rb proteins, pointing to a genetic interaction between APC/C^CDH1^ and the SynMuv B group of genes ([@R17]). Finally, it is notable that Sin3B inactivation prevents oncogene-induced senescence, both *in vitro* and *in vivo*. This is reminiscent of what has been reported for the DREAM complex, whereby its inactivation allows the cells to escape from Ras-induced senescence ([@R2]; [@R21]; [@R33]; [@R42]; [@R57]). Whether activation of the DREAM-Sin3B-dependent repression of cell-cycle genes can serve as a tumor suppressor mechanism *in vivo* remains unclear. Furthermore, the identity of the additional events that sensitize Sin3B-DREAM-null cells to transformation remains to be elucidated, but this study warrants further investigation of the contribution of this transcriptional repression pathway in the biological settings of uncontrolled proliferation.

STAR ★METHODS {#S10}
=============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S11}
----------------------------------------

Further information and requests for resources and reagetns should be directed to and will be fullfilled by the Lead contact, Gregory David (<gregory.david@nyumc.org>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

### Cell culture {#S13}

MEFs (both males and females) were cultured in DMEM (Cellgro), 10% fetal bovine serum, 1% Penicillin/Streptomycin (Cellgro), 2.5 μg/mL Puromycin (GIBCO), and 50 μg/mL Hygromycin B (Invitrogen). T98G cells (glioblastoma cells from a male individual, obtained from ATCC) were cultured in DMEM (Cellgro), 10% fetal bovine serum, and 1% penicillin/streptomycin (Cellgro). T98G cells with RNAi were cultured in DMEM (Cellgro), 10% fetal bovine serum, 1% penicillin/streptomycin (Cellgro), and 1 μg/mL Puromycin (GIBCO). T98G cells engineered with the FUCCI probes and pTRIPZ-EMI1-FLAG were cultured in DMEM (Cellgro), 10% fetal bovine serum, 1% penicillin/streptomycin (Cellgro), 1 μg/mL Puromycin (GIBCO), 150 μg/mL Hygromycin B (Invitrogen), and 10 μg/mL Blasticidin (Invivogen). HEK293T cells (from a female fetus) cultured in DMEM (Cellgro), 10% donor calf serum, and 1% penicillin/streptomycin (Cellgro). NIH 3T3 cells were cultured in DMEM (Cellgro), 10% fetal bovine serum, 1% penicillin/streptomycin (Cellgro), and 2.5 μg/mL Puromycin (GIBCO). 0.5 μg/mL doxycycline was the working concentration for all doxycycline systems. All cultures were maintained in 5% CO~2~ at 37°C. Regarding mice use for the generation of MEFs, all animal work was approved by the NYULMC Institutional Animal Care & Use committee.

METHOD DETAILS {#S14}
--------------

### Derivation of MEFs {#S15}

MEFs deleted for Sin3B were isolated as previously described ([@R12]). Once established, cells were passaged until stochastic immortalization occurred. These cells were then clonally amplified, yielding a clonal, immortalized MEF cell line.

### Establishment of Sin3B null CRISPR cell lines {#S16}

T98G cells were transiently transfected with two independent sgRNA guide pairs cloned into the pX330 hSpCas9 plasmid, which targeted exon 2 of Sin3B. Cells were selected, clonally amplified and assessed for Sin3B deletion via two independent antibodies targeting Sin3B (Sin3B AK12 and Sin3B H4 listed below).

### Plasmids {#S17}

Stable cell lines in mouse cells were generated using the pCL vector for retroviruses. Stable cell lines in human cells were generated using VSV-G and Gag-Pol vectors for retroviruses. All lentiviral stable cells lines were generated using psPAX2 and pMD2.G vectors. Sin3B-FLAG, and all Sin3B-FLAG truncation mutants were cloned in the pcDNA3.1+ construct. Sin3B-FLAG point mutants were cloned in pcDNA3.1+ for transient transfection and pBABE-puro for retroviral transduction. The following constructs were used for stable transduction: pTRIPZ-EMI1-FLAG Puromycin, pBABE V5-LIN37 Hygromycin ([@R32]), pFUCCI-G~1~ Orange MaRX IVf hygro, and pFUCCI-S/G~2~/M Green pLB(N)CX Blasticidin. The following constructs were used for transient transfection: LIN9-V5 HIS pEF, LIN37-V5 HIS pEF, p107-HA pCMV, MYC-FOXM1, p130-HA pcDNA3.1+, and BMYB-V5 pcDNA3.1+. A pTRIPZ Puromycin lentiviral doxycycline-inducible short hairpin against human Sin3B was purchased from Dharmacon, V3THS_315587 (AGGCTGTAGACATCGTCCA).

### Antibodies {#S18}

The following antibodies were used for immunoblotting: mouse anti-Sin3B (Santa Cruz H-4 SC-13145), mouse anti-Sin3B (Santa Cruz H-5 SC-55516), rabbit anti-Sin3B (Santa Cruz AK-12), rabbit anti-Sin3A (Santa Cruz K-20), rabbit anti-KI67 (Millipore (Upstate) AB9260), mouse anti-a-tubulin (Sigma-Aldrich T9026), mouse anti-vinculin (Sigma Clone V9131), rabbit anti-vinculin (Cell Signaling 13901), rabbit anti-MYBL2 (Santa Cruz SC-724 N-19), mouse anti-p130 (BD Transduction Labs 610262), rabbit anti-p130 (Santa Cruz C-20 SC-317), mouse anti-CCND1 (Millipore/Calbiochem CC12), rabbit anti-CDKN1B (p27KIP1) (Cell Signaling 2552), rabbit anti-CCNA2 (Santa Cruz C-19 SC-596), mouse anti-CCNE1 (Santa Cruz HE12 SC247), rabbit anti-CCNF (Santa Cruz C-20 SC952), rabbit anti-CDKN1A (p21CIP1) (Santa Cruz C-19), mouse anti-GAPDH (Millipore MAB374), mouse anti-FLAG (M2 Sigma), mouse anti-HA (Sigma 12CA5), mouse anti-MYC tag (Cell Signaling 9B11), rabbit anti-HDAC1 (Cell Signaling D5C6VXP), rabbit anti-HDAC3 (Cell Sigaling \#2632), and mouse anti-V5 (Invitrogen). The following antibodies were used for immunoprecipitation: rabbit IgG (Bethyl P120-101), rabbit anti-V5 (Bethyl A190-120-A), mouse anti-HA (Santa Cruz 7392), mouse anti-Sin3B (Santa Cruz H-4 SC-13145), mouse anti-V5 (Invitrogen), and mouse anti-FLAG EZview Red ANTI-FLAG M2 Affinity Gel (Sigma F2426). Rabbit antibodies against LIN9 and LIN37 used for immunoprecipitation and western blots were prepared by Bethyl and previously descibed ([@R32]).

### Mass spectrometry {#S19}

Nuclear extracts were prepared from cells stably expressing Sin3B-FLAG and various Sin3B-FLAG mutants, and incubated with EZview Red ANTI-FLAG M2 affinity gels overnight. Proteins were competitively eluted via Flag peptide and standard binding partner characterization was performed using the Orbitrap Fusion mass spectrometer to acquire high resolution MS and MS/MS spectra of eluted peptides. These data were then searched against the Uniprot mouse database using Sequest in order to generate a list of peptide interactors.

### Nuclear lysate extraction {#S20}

Nuclei were extracted by quick lysis in RSB-G40 lysis buffer (10mM Tris 7.4, 10mM NaCl, 3 mM MgCl~2~, 10% glycerol, 0.25% NP-40, 0.5 mM DTT, 25 mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and cOmplete protease inhibitor cocktail (Sigma)). Nuclei were washed with RSB-G40 without NP-40, and lysed with high-salt extraction buffer (20 mM HEPES pH7.9, 420mM NaCl, 1.5 mM MgCl~2~, 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT, 25 mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and cOmplete protease inhibitor cocktail (Sigma)). Salt concentrations were adjusted with the addition of binding buffer (20mM HEPES pH7.9, 5 mM MgCl~2~, 10% glycerol, 0.1% Tween-20, 0.5 mM DTT, 25 mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and cOmplete protease inhibitor cocktail (Sigma)), and lysates were subjected to either electrophoresis or immunoprecipiation.

### Transient transfection co-immunoprecipitations {#S21}

HEK293T, T98G, or NIH 3T3 cells were transfected with 10 μg of the indicated constructions using a 4:1 ratio of polyethyleneimine (PEI). Cells were incubated for 48 hr, harvested and lysed with 1x EBC buffer (120 mM NaCl, 0.5% v/v NP-40, 50 mM Tris-HCl pH 8.0, 0.01% 2-Mercaptoethanol, 25 mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and cOmplete protease inhibitor cocktail (Sigma)). Lysates were incubated with equilibrated mouse anti-FLAG EZview Red ANTI-FLAG M2 Affinity Gel (Sigma F2426) overnight at 4°C with gentle rotation. Beads were washed and protein was eluted via boiling in Laemmli buffer (2x Laemmli buffer: 4% w/v SDS, 20% v/v glycerol, 120 mM Tris-HCl pH 6.8). Eluted lysates were subjected to electrophoresis followed by immunoblotting.

### Endogenous and semi-endogenous immunoprecipitations {#S22}

T98G or NIH 3T3 cells transfected or stably infected with the indicated constructs were harvested on ice and lysed in EBC buffer (50 mM TRIS-HCl pH 8.0, 150 mM NaCl, 0.5% NP-40, 0.5 mM EDTA) ([@R32]) supplemented with 0.01% 2-mercaptoethanol, protease inhibitors (EMD; Cat\#539131, Cocktail Set-I) and phosphatase inhibitors (EMD; Cat\#524625, Cocktail Set-II). Protein concentrations were measured using DC protein assay kit (Bio-Rad), lysates were normalized and immunoprecipitated with the indicated antibodies (1 μg/ml) using Protein A Sepharose CL-4B Beads (GE Healthcare).

### Immunoblot analysis {#S23}

Cells were lysed in 1x RIPA buffer (1% NP-40, 0.1% SDS, 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% sodium deoxycholate, 1 mM EDTA) for whole cell extracts, or 1x EBC buffer (120 mM NaCl, 0.5% v/v NP-40, 50 mM Tris-HCl pH 8.0) for immunoprecipitations, 0.5 μM DTT (0.01% 2-Mercaptoethanol for EBC buffer), 25 mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and cOmplete protease inhibitor cocktail (Sigma). PVDF membranes were blocked in 5% milk/0.1% Tween 20 TBS for 1 hr at room temperature. Primary antibodies were incubated overnight at 4°C. After incubation with either the secondary IRDye Alexa Fluor 680 goat antimouse antibody or 800 goat anti-rabbit antibodies (Odyssey), the membranes were visualized with the Odyssey Infrared Imaging System (Li-Cor). Immunoprecipitations: whole cell lysates (10% inputs) and immunoprecipitates were resolved on 4%--15% gradient Criterion gels (BioRad) and transferred to nitrocellulose membranes using semi-dry Transblot SD cell (BioRad). ReliaBLOT kit (Bethyl Labs; WB120) was used for IP/western blotting according to manufacturer's protocol and membranes were probed with indicated antibodies.

### KI67 staining {#S24}

Cells were starved for 72hrs using DMEM (Cellgro) with 0% FBS and 1% Penicillin/Streptomycin (Cellgro) at \< 100% confluency. Cells were then fixed in 70% ethanol, added dropwise while vortexing, at 4°C overnight. Staining was performed overnight at 4°C in the dark using 200,000 cells in 100 μL 1% BSA/PBS using 1 μL anti-mouse KI67 APC (Biolegend 16A8) or 1 uL rat anti-IgG2a κ Isotype control APC (Biolegend RTK2758). Cells were stained using 10 μg/mL Hoechst in 200 μL PBS at room temperature for 10 mins, filtered, and analyzed via flow cytometry using a FACSCalibur Flow Cytometer (BD). A minimum of 30,000 events were counted for each sample.

### BrDU staining {#S25}

Cells were starved for 72hrs using DMEM (Cellgro) with 0% FBS and 1% Penicillin/Streptomycin (Cellgro) at \< 100% confluency. Cells were pulsed with 30 μM BrDU for 2 hours. Cells were then fixed in 70% ethanol, added drop wise while vortexing, at 4°C overnight. Chromatin was exposed via 2N HCL and 0.5% Triton X-100, added drop wise while vortexing, at room temperature for 30 mins. HCL was neutralized via 30 min incubation at room temperature with 0.1 M sodium tetraborate (Na~2~B~4~O~7~ · 10 H~2~O), pH 8.5.200,000 cells were stained with 1 μL anti-BrDU FITC (BD PharMingen) in 100 μL 0.5% Tween 20/1% BSA/PBS for 30 mins in the dark at room temperature. Cells were then stained with 100 μg/mL propidium iodide, filtered and analyzed via flow cytometry using a FACSCalibur Flow Cytometer (BD). A minimum of 30,000 events were counted for each sample.

### Propidium iodide staining {#S26}

Cells were starved for 72hrs using DMEM (Cellgro) with 0% FBS and 1% Penicillin/Streptomycin (Cellgro) at \< 100% confluency. Cells were restimulated with 10% serum for the 0, 10 and 18 hours and fixed in 70% ethanol, added drop wise while vortexing, at 4°C overnight. Cells were washed twice with PBS and stained overnight at 4°C using 100 μg/mL propidium iodide. Cells were filtered and analyzed via flow cytometry using a FACSCalibur Flow Cytometer (BD). A minimum of 30,000 events were counted for each sample.

### Chromatin Immunoprecipitation (ChIP) {#S27}

Cells were serum starved for 72 hours and lyzed in the presence of Trichostatin A and protease inhibitors. ChIP was performed as previously ([@R13]; [@R21]) using 750 μg proteins from whole cell extractswith 2 μg of the following antibodies. Sin3B (SCBT, H4); H3 (Abcam, ab17911), acK9-H3 (EMD Millipore, 06-942), E2F4 (SCBT, D7), and c-kit (SCBT, M14). qRT-PCR was performed using primers previously described ([@R36]).

### RNA preparation for sequencing {#S28}

Cells were starved for 72hrs using DMEM (Cellgro) with 0% FBS and 1% Penicillin/Streptomycin (Cellgro) at \< 100% confluency. Cells were restimulated with 10% serum for the 0, 10 and 18 hours and harvested for RNA. RNA was extracted via column purification using RNeasy Mini Kit (QIAGEN).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S29}
---------------------------------------

### Statistics {#S30}

All data were analyzed by Student's t test (unpaired, 2-tailed) and results were considered significant at p \< 0.05. Results are presented as mean ± SEM.

### RNA sequencing {#S31}

Raw reads were trimmed by performing a sliding window trimming using Trimmomatic (version 0.33) with a window size of 4 and quality threshold of 10 ([@R7]). Reads were aligned to the genome using Tophat (version 2.1.1) with default settings ([@R56]). For each gene, read counts were assigned using HTSeq-count. To determine differential expression between experiment and control groups, the edgeR statistical package was used and the generalized linear model likelihood ratio test applied using the function glmLRT() ([@R43]). Differentially expressed genes were determined as genes with false discovery rate \< 0.1.

DATA AND SOFTWARE AVAILABILITY {#S32}
------------------------------

The accession numbers for the sequencing data reported in this paper are on GEO repository GSE121857 and can be accessed at <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121857>.
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![Identification of Sin3B's Canonical and Additional Interactors\
(A) Normalized peptide-spectrum match (PSM) values of canonical and additional interactors. PSM % is the PSM value of each protein normalized to Sin3B signal, related as a percentage. RPD3L, large Sin3 complex; RPD3S, small Sin3 complex.\
(B) Co-immunoprecipitations with an anti-FLAG antibody of whole-cell extracts from T98G cells transfected with the indicated plasmids. Immunoblots were performed using the indicated antibodies. 10% input. IP, immunoprecipitation.\
(C) Co-immunoprecipitations with an anti-FLAG antibody of whole-cell extracts from T98G cells transiently transfected with Sin3B-FLAG or empty vector (EV). Immunoblots were performed using the indicated antibodies. 10% input. IP, immunoprecipitation.](nihms-1516646-f0002){#F1}

![Sin3B Interacts with the DREAM Complex\
(A) Co-immunoprecipitation using an anti-LIN37 antibody of whole-cell extracts from human T98G cells (left) or mouse NIH 3T3 cells (right) transiently transfected with Sin3B-FLAG or empty vector (EV). Immunoblots were performed using the indicated antibodies. 10% input. IP, immunoprecipitation. Top arrow, endogenous Sin3B; bottom arrow, exogenous Sin3B. IgG, immunoglobulin G.\
(B) Co-immunoprecipitation on endogenous proteins using an anti-Sin3B antibody of whole-cell extracts from T98G cells either asynchronously growing (Async) or serum starved for 72 hr (T0). Immunoblots were performed using the indicated antibodies. 10% input. IP, immunoprecipitation; IgG, immunoglobulin G.\
(C) Left panels: western blot of whole-cell extracts from T98G cells asynchronously growing (Async), serum starved for 72 hr (T0), and serum starved for 72 hr and released for 6--26 hr (T6 to T26) with the indicated antibodies. Right panel: co-immunoprecipitation on endogenous proteins using an anti-Sin3B antibody of same whole-cell extracts. 10% input. IP, immunoprecipitation; IgG, immunoglobulin G.\
(D) Co-immunoprecipitation on endogenous proteins using an anti-Lin9 antibody (left panel) or Lin37 antibody (right panel) from growing NIH 3T3 (wild-type \[WT\]) or Rb-p107-p130 triple knockout spontaneously immortalized mouse embryonic fibroblasts (MEFs) (TKO). Immunoblots were performed using the indicated antibodies. 10% input. IP, immunoprecipitation; IgG, immunoglobulin G.](nihms-1516646-f0003){#F2}

![Sin3B Is Required for the Repression of DREAM Target Genes\
(A) Western blot on whole-cell lysate from T98G cells of the indicated genotypes 0 (T0), 10 (T10), and 18 hr (T18) post serum addition and probed using the indicated antibodies.\
(B) RNA from T98G cells harvested at the indicated time points was used for deep sequencing. Differential gene expression was performed comparing the averaged wild-type and Sin3B-deleted cell lines at T0. A heatmap representing the expression of the 429 significantly de-repressed genes at T0 is shown here at all time points.\
(C) qRT-PCR for the indicated DREAM target genes in serum-starved Sin3B^+/+^ and Sin3B^−/−^ T98G. n = 6(3 biological replicates using at least 2 independent cell lines per genotype for each point). Error bars represent SEM.\
(D) qRT-PCR for the indicated DREAM target genes in serum-starved Sin3B^+/+^, Sin3B^−/−^, and Sin3B^−/−^ T98G cells stably expressing FLAG-tagged Sin3B (n = 4 biological replicates).\
(E) Chromatin immunoprecipitation (ChIP) in serum-starved Sin3B^+/+^ (red bars) and Sin3B^−/−^ (blue bars) T98G cells for Sin3B (left), E2F4 (middle), or AcK9-H3/total H3 (right), at the promoter of the indicated genes. An antibody raised against c-kit is used as control (Irr Ab). Shown is the average of three independent biological replicates, and error bars represent SEM.](nihms-1516646-f0004){#F3}

![Sin3B Is Not Required for Entry into Quiescence\
(A) Western blot for two independent Sin3B wild-type (left) and two independent Sin3B knockout (right) T98G cell lines. Immunoblotting was performed using 40 μg of whole-cell lysates probed using the indicated antibodies.\
(B) Representative flow plots of KI67 staining in Sin3B^+/+^ and Sin3B^−/−^ T98G cells. Cells were stained for KI67. Cycling, asynchronous, cycling cells; Sync, serumstarved cells for 72 hr; Isotype, isotype control antibody.\
(C) Quantification of KI67 mean fluorescence intensity (MFI) from (A). n = 4 (2 independent cell lines per genotype with 2 experimental replicates each).\
(D) Representative flow plots of BrdU staining in Sin3B^+/+^ and Sin3B^−/−^ T98G cells. Cells were starved for 72 hr, pulsed for 2 hr with BrdU, and stained.\
(E) Propidium iodide flow plots from (D).\
(F) Quantification of (C). n = 4 (2 independent cell lines per genotype with 2 experimental replicates each).\
(G) Representative flow plots of PI staining for Sin3B^+/+^ and Sin3B^−/−^ T98G cells, synchronized in G~0~ by serum deprivation for 72 hr (T0) or release upon addition of serum for 10 hr (T10) or 18 hr (T18).\
(H) Sin3B^+/+^ and Sin3B^−/−^ T98G cells expressing FUCCI probes (RFP, pFUCCI-G~1~; GFP, pFUCCI-S/G~2~/M) were serum deprived for 72 hr and released into 10% serum for the indicated time, and the amount of RFP and GFP fluorescence was quantified. n = 6 (2 independent cell lines per genotype with 3 technical replicates each).](nihms-1516646-f0005){#F4}

![Inhibition of APC/C^CDH1^ Is Sufficient to Cause Quiescent Sin3B-Deleted Cells to Re-enter the Cell Cycle\
(A) Immunoblots with the indicated antibodies of whole-cell lysate from two independent Sin3B^+/+^ and two independent Sin3B^−/−^ T98G serum-starved cell lines infected with a doxycycline-inducible Emi1 expression vector. Cells were kept in no-serum conditions and doxycycline was added for 24 hr(T24) or 48 hr (T48).\
(B) FUCCI-expressing T98G cells were serum deprived for 96 hr prior to doxycycline administration to induce EMI1 expression. Positivity for the FUCCI probes was quantified at 24 and 48 hr post doxycycline addition. Cells expressing Cdt1-RFP were counted as in G~0~/G~1~ phase, cells expressing geminin1-GFP as in S/G~2~/M phases, and cells expressing both Cdt1-RFP and gemini1-GFP as in G~1~/S. For each condition, at least two independent experiments with each cell line presented in (A) were performed.\
(C) FUCCI expressing T98G cells were serum deprived for 96 hr prior to the addition of proTAME. Positivity for the FUCCI probes was quantified at 24 and 48 hr post doxycycline addition to inhibit APC/C^CDH1^ activity. \*p \< 0.05.](nihms-1516646-f0006){#F5}

###### 

KEY RESOURCES TABLE

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  REAGENT or RESOURCE                                                                                                                      SOURCE                     IDENTIFIER
  ---------------------------------------------------------------------------------------------------------------------------------------- -------------------------- -------------------------------------------------------------------------------------------------------------------------------
  Antibodies                                                                                                                                                          

                                                                                                                                                                      

  Mouse monoclonal anti-Sin3B (clone H-4)                                                                                                  Santa Cruz                 sc-13145; RRID: AB_628254

  Mouse monoclonal anti-Sin3B (clone H-5)                                                                                                  Santa Cruz                 sc-55516; RRID: AB_2197789

  Rabbit polyclonal anti-Sin3B (AK-12)                                                                                                     Santa Cruz                 sc-758

  Rabbit polyclonal anti-Sin3A (K-20)                                                                                                      Santa Cruz                 sc-994; RRID: AB_2187760

  Rabbit polyclonal anti-Ki67                                                                                                              Millipore Sigma            AB9260; RRID: AB_2142366

  Mouse monoclonal anti-α-Tubulin (clone DM1A)                                                                                             Millipore Sigma            T9026; RRID: AB_477593

  Mouse monoclonal anti-α-Tubulin (clone DM1A)                                                                                             Cell Signaling             3873; RRID: AB_1904178

  Mouse monoclonal anti-Vinculin (clone hVIN-1)                                                                                            Millipore Sigma            V9131: RRID: AB_477629

  Rabbit monoclonal anti-Vinculin (clone E1E9V)                                                                                            Cell Signaling             13901; RRID: AB_2728768

  Rabbit polyclonal anti-B-Myb (N-19)                                                                                                      Santa Cruz                 sc-724; RRID: AB_631985

  Mouse monoclonal anti-Rb (clone Rb1)                                                                                                     Santa Cruz                 Sc-73598; RRID: AB_1128965

  Mouse monoclonal anti-Rb2 (clone 10/Rb2)                                                                                                 BD Transduction Labs       610262; RRID: AB_397657

  Rabbit polyclonal anti-p130 (C-20)                                                                                                       Santa Cruz                 sc-317; RRID: AB_632093

  Mouse monoclonal anti-Cyclin D1 (clone DCS-6)                                                                                            Millipore Sigma            CC12; RRID: AB_2070408

  Rabbit polyclonal anti-p27 Kip1                                                                                                          Cell Signaling             2552; RRID: AB_10693314

  Rabbit polyclonal anti-Cyclin A (C-19)                                                                                                   Santa Cruz                 sc-596; RRID: AB_631330

  Rabbit polyclonal anti-Cyclin A2                                                                                                         M. Pagano (NYU)            N/A

  Mouse monoclonal anti-Cyclin E (clone HE12)                                                                                              Santa Cruz                 sc-247; RRID: AB_627357

  Rabbit polyclonal anti-Cyclin F (C-20)                                                                                                   Santa Cruz                 sc-952; RRID: AB_2071212

  Rabbit polyclonal anti-p21 (C-19)                                                                                                        Santa Cruz                 sc-397; RRID: AB_632126

  Mouse monoclonal anti-GAPDH (clone 6C5)                                                                                                  Millipore Sigma            MAB374; RRID: AB_2107445

  Rabbit monoclonal anti-HDAC1 (clone D5C6U)                                                                                               Cell Signaling             34589

  Rabbit polyclonal anti-HDAC3                                                                                                             Cell Signaling             2632; RRID: AB_331545

  Rabbit polyclonal anti-Histone H3                                                                                                        Abcam                      ab1791; RRID: AB_302613

  Rabbit polyclonal anti-αcetyl-Histone H3 (Lys9)                                                                                          Millipore Sigma            06--942; RRID: AB_310308

  Mouse monoclonal anti-E2F4 (clone D7)                                                                                                    Santa Cruz                 sc-398543

  Goal polyclonal anti-cKit (M-14)                                                                                                         Santa Cruz                 sc-1494; RRID: AB_631032

  Mouse monoclonal FITC anti-BrdU (clone 3D4)                                                                                              BioLegend                  364103; RRID: AB_2564480

  Rat monoclonal APC anti-Ki67 (clone 16A8)                                                                                                BioLegend                  652405; RRID: AB_2561929

  Rabbit anti-Lin9                                                                                                                         ([@R32])                   N/A

  Rabbit anti-Lin37                                                                                                                        ([@R32])                   N/A

  Mouse monoclonal Anti-FLAG (clone M2)                                                                                                    Millipore Sigma            F1804; RRID: AB_262044

  EZview Red ANTI-FLAG tag M2 Affinity Gel                                                                                                 Millipore Sigma            F2426; RRID: AB_2616449

  Mouse monoclonal anti-HA tag (clone 12CA5)                                                                                               Millipore Sigma            SAB1305536; RRID: AB_514505

  Mouse monoclonal anti-HA tag (clone F-7)                                                                                                 Santa Cruz                 sc-7392; RRID: AB_627809

  Mouse monoclonal anti-Myc tag (clone 9B11)                                                                                               Cell Signaling             2276; RRID: AB_331783

  Mouse monoclonal anti-V5 tag                                                                                                             ThermoFisher               R960--25; RRID: AB_2556564

  Rabbit polyclonal anti-V5 tag                                                                                                            Bethyl Laboratories        A190--120A; RRID: AB_67586

  Goat polyclonal IRDye 680RD anti-mouse IgG (H+L)                                                                                         Li-Cor                     925--68070; RRID: AB_2651128

  Goat polyclonal IRDye 800CW anti-rabbit IgG (H+L)                                                                                        Li-Cor                     925--32211; RRID: AB_2651127

  Purified Rat APC IgG2a κ Isotype                                                                                                         BioLegend                  400511; RRID: AB_2561754

  Purified Rabbit IgG                                                                                                                      Bethyl Laboratories        P120--101; RRID: AB_479829

                                                                                                                                                                      

  Bacterial and vairus strains                                                                                                                                        

                                                                                                                                                                      

  DH5α (*E. coli*)                                                                                                                         New England Biolabs        C2988J

                                                                                                                                                                      

  Biological Samples                                                                                                                                                  

                                                                                                                                                                      

  N/A                                                                                                                                      N/A                        N/A

                                                                                                                                                                      

  Chemicals, Peptides, and Recombinant Proteins                                                                                                                       

                                                                                                                                                                      

  Fetal Bovine Serum (Premium)                                                                                                             Atlanta Biologicals        S11150

  Donor Bovine Serum                                                                                                                       Atlanta Biologicals        S11350

  FLAG Peptide                                                                                                                             Millipore Sigma            F3290

  proTAME                                                                                                                                  Boston Biochem             I-440

  Propidium Iodide                                                                                                                         Millipore Sigma            P4170

  Sodium Orthovanadate (Na~3~VO~4~)                                                                                                        NEB                        P0758S

  Sodium Fluoride (NaF)                                                                                                                    Millipore Sigma            201154

  Dithiothreitol (DTT)                                                                                                                     ThermoFisher               R0861

  Phenylmethylsulfonyl fluoride (PMSF)                                                                                                     ThermoFisher               36978

  cOmplete Protease Inhibitor Cocktail                                                                                                     Millipore Sigma            11697498001

  Polyethylenimine, Linear (MW 25,000)                                                                                                     Polysciences, Inc          23966

  2-Mercaptoethanol                                                                                                                        Millipore Sigma            M3148

  Protease Inhibitor Cocktail Set I                                                                                                        Millipore Sigma            539131

  Phosphatase Inhibitor Cocktail Set II                                                                                                    Millipore Sigma            524625

  Protein A Sepharose CL-4B                                                                                                                GE Healthcare              17078001

  Criterion gels                                                                                                                           BioRad                     5678083

  Hoechst 33342                                                                                                                            Millipore Sigma            B2261

  Sodium tetraborate                                                                                                                       Millipore Sigma            221732

  Trichostatin A                                                                                                                           Millipore Sigma            T8552

                                                                                                                                                                      

  Critical Commercial Assays                                                                                                                                          

                                                                                                                                                                      

  DC Protein Assay kit                                                                                                                     Bio-Rad                    5000111

  BCA Protein Assay Kit                                                                                                                    ThermoFisher               23225

  RNeasy Mini Kit                                                                                                                          QIAGEN                     74104

  FITC BrdU Flow kit                                                                                                                       BD Pharmingen              559619

  ReliaBLOT IP/Western Blot                                                                                                                Bethyl Laboratories        WB120

                                                                                                                                                                      

  Deposited Data                                                                                                                                                      

                                                                                                                                                                      

  RNA-Seq                                                                                                                                  This work                  GEO: GSE121857; <https://www.ncbi.nlm.nih.gov/gds>; GSE121857

                                                                                                                                                                      

  Experimental Models: Cell Lines                                                                                                                                     

                                                                                                                                                                      

  Human: T98G                                                                                                                              ATCC                       CRL-1690

  T98G Sin3B WT (D11)                                                                                                                      This work                  N/A

  T98G Sin3BKO (G6)                                                                                                                        This work                  N/A

  T98G Sin3BKO (B5)                                                                                                                        This work                  N/A

  T98G + EV (pcDNA3.1 + transient transfection)                                                                                            This work                  N/A

  T98G + Sin3B-FLAG (pcDNA3.1+ transient transfection)                                                                                     This work                  N/A

  T98G Sin3BKO (G6) + EV (pBabe puro -- retrovirus)                                                                                        This work                  N/A

  T98G Sin3BKO (G6) + Sin3B-FLAG (pBabe puro -- retrovirus)                                                                                This work                  N/A

  T98G + Lin9-V5-His (pEF6 -- transient transfection)                                                                                      This work                  N/A

  T98G + Lin9-V5-His (pEF6 -- transient transfection) + Sin3B-FLAG (pcDNA3.1+ transient transfection)                                      This work                  N/A

  T98G + shSCRAMBLE (pTRIPZ -- lentivirus)                                                                                                 This work                  N/A

  T98G + shSin3B (pTRIPZ -- lentivirus)                                                                                                    This work                  N/A

  T98G + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus)                                                        This work                  N/A

  T98G WT (D11) + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus)                                               This work                  N/A

  T98G Sin3BKO (G6) + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus)                                           This work                  N/A

  T98G Sin3BKO (B5) + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus)                                           This work                  N/A

  T98G + Emi1-FLAG (pTRIPZ-Puro -- lentivirus)                                                                                             This work                  N/A

  T98G WT (D11) + Emi1-FLAG (pTRIPZ-Puro -- lentivirus)                                                                                    This work                  N/A

  T98G Sin3B (G6) + Emi1-FLAG (pTRIPZ-Puro -- lentivirus)                                                                                  This work                  N/A

  T98G Sin3BKO (B5) + Emi1-FLAG (pTRIPZ-Puro -- lentivirus)                                                                                This work                  N/A

  T98G + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus) + Emi1-FLAG (pTRIPZ-Puro -- lentivirus)                This work                  N/A

  T98G WT (D11) + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus) + Emi1-FLAG (pTRIPZ-Puro -- lentivirus)       This work                  N/A

  T98G Sin3BKO (G6) + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus) + Emi1-FLAG                               This work                  N/A

  T98G Sin3BKO (B5) + Cdt1-mKO2 (MaRX hygro -- retrovirus) + hGmnn-mAG1 (pLB(N)CX -- retrovirus) + Emi1-FLAG (pTRIPZ-Puro -- lentivirus)   This work                  N/A

  Human: HEK293T                                                                                                                           ATCC                       CRL-3216

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection) +\                                                                                This work                  N/A
  EV (pcDNA3.1+ transient transfection)                                                                                                                               

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection) + Sin3B-FLAG (pcDNA3.1 + transient transfection)                                  This work                  N/A

  HEK293T + Lin37-V5-His (pEF6 -- transient transfection) +\                                                                               This work                  N/A
  EV (pcDNA3.1+ transient transfection)                                                                                                                               

  HEK293T + Lin37-V5-His (pEF6 -- transient transfection) + Sin3B-FLAG (pcDNA3.1 + transient transfection)                                 This work                  N/A

  HEK293T + Bmyb-V5 (pcDNA3.1 + transient transfection) + EV (pcDNA3.1+ transient transfection)                                            This work                  N/A

  HEK293T + Bmyb-V5 (pcDNA3.1 + transient transfection) + Sin3B-FLAG (pcDNA3.1 + transient transfection)                                   This work                  N/A

  HEK293T + p107-HA (pCMV -- transient transfection) +\                                                                                    This work                  N/A
  EV (pcDNA3.1+ transient transfection)                                                                                                                               

  HEK293T + p107-HA (pCMV -- transient transfection) + Sin3B-FLAG (pcDNA3.1 + transient transfection)                                      This work                  N/A

  HEK293T + p130-HA (pcDNA3.1+ transient transfection) +\                                                                                  This work                  N/A
  EV (pcDNA3.1+ transient transfection)                                                                                                                               

  HEK293T + p130-HA (pcDNA3.1+ transient transfection) + Sin3B-FLAG (pcDNA3.1 + transient transfection)                                    This work                  N/A

  HEK293T + Foxm1 (pMyc -- transient transfection) +\                                                                                      This work                  N/A
  EV (pcDNA3.1+ transient transfection)                                                                                                                               

  HEK293T + Foxm1 (pMyc -- transient transfection) + Sin3B-FLAG (pcDNA3.1 + transient transfection)                                        This work                  N/A

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection)                                                                                   This work                  N/A

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection) + Sin3BDHID-FLAG (pcDNA3.1 + transient transfection)                              This work                  N/A

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection) + Sin3B (1-304)-FLAG (pcDNA3.1 + transient transfection)                          This work                  N/A

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection) + Sin3B (1-510)-FLAG (pcDNA3.1 + transient transfection)                          This work                  N/A

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection) + Sin3B (305-1098)-FLAG (pcDNA3.1+ transient transfection)                        This work                  N/A

  HEK293T + Lin9-V5-His (pEF6 -- transient transfection) + Sin3B (511-1098)-FLAG (pcDNA3.1+ transient transfection)                        This work                  N/A

  Mouse: Embryonic Fibroblasts (Sin3B KO)                                                                                                  ([@R12])                   N/A

  MEF Sin3BKO + EV (pBabe puro -- retrovirus)                                                                                              This work                  N/A

  MEF Sin3BKO + Sin3B-FLAG (pBabe puro -- retrovirus)                                                                                      This work                  N/A

  Mouse: Embryonic Fibroblasts (Rb KO; p107 KO; p130 KO) (Triple Knock Out, TKO)                                                           ([@R10])                   N/A

  Mouse: NIH 3T3                                                                                                                           ATCC                       CRL-1658

  NIH 3T3 + EV (pcDNA3.1 + transient transfection)                                                                                         This work                  N/A

  NIH 3T3 + Sin3B-FLAG (pcDNA3.1+ transient transfection)                                                                                  This work                  N/A

                                                                                                                                                                      

  Experimental Models: Organisms/Strains                                                                                                                              

                                                                                                                                                                      

  Mouse: Sin3B-KO                                                                                                                          ([@R12])                   N/A

  Mouse: TKO (Rb KO; p107 KO; p130 KO) (Triple Knock\                                                                                      ([@R10])                   N/A
  Out, TKO)                                                                                                                                                           

                                                                                                                                                                      

  Oligonucleotides                                                                                                                                                    

                                                                                                                                                                      

  pTRIPZ-shSin3B-Puromycin (AGGCTGTAGACATCGTCCA)                                                                                           Dharmacon                  V3THS_315587

  Sin3B gRNA \#1 FWD: CACCGACCAGGTGAAGATCCGCTT                                                                                             IDT                        N/A

  Sin3B gRNA \#2 FWD: CACCGAGAAGACGCCCTCACCTATC                                                                                            IDT                        N/A

  Sin3B gRNA \#3 FWD: CACCGTGCCAAAGCGGATCTTCACC                                                                                            IDT                        N/A

  Sin3B gRNA \#4 FWD: CACCGATCTCCAGGAAGCCGTTGT                                                                                             IDT                        N/A

  Sin3B gRNA \#4 FWD: CACCGATCTCCAGGAAGCCGTTGT                                                                                             IDT                        N/A

  Sin3B gRNA \#5 FWD: CACCGCTCCAGGAAGCCGTTGTAGG                                                                                            IDT                        N/A

  Sin3B gRNA \#6 FWD: CACCGTCACCTGGTCCAGATAGGTG                                                                                            IDT                        N/A

                                                                                                                                                                      

  Recombinant DNA                                                                                                                                                     

                                                                                                                                                                      

  Plasmid: pcDNA3.1 +                                                                                                                      ThermoFisher               V79020

  Plasmid: pCL-Eco                                                                                                                         Addgene                    12371

  Plasmid: VSV.G                                                                                                                           Addgene                    14888

  Plasmid: Gag/Pol                                                                                                                         Addgene                    14887

  Plasmid: psPAX2                                                                                                                          Addgene                    12260

  Plasmid pMD2.G                                                                                                                           Addgene                    12259

  Plasmid: pBABE-Puro                                                                                                                      Addgene                    1764

  Plasmid: px330-hSpCas9                                                                                                                   Addgene                    42230

  Plasmid: pLB(N)CX                                                                                                                        J. DeCaprio (DF/HCC)       N/A

  Plasmid: MaRX Ivf Hygromycin                                                                                                             R. DePinho (MD Anderson)   N/A

  Plasmid: pFucci-G1 Orange Cloning Vector (Cdt1-mKO2)                                                                                     MBL                        AM-V9001M

  Plasmid: pFucci-S/G2/M Green Cloning Vector (hGmnn-hmAGI)                                                                                MBL                        AM-V9012M

  Plasmid: pcDNA3.1-Cdt1-mKO2                                                                                                              This work                  N/A

  Plasmid: pcDNA3.1-hGmnn-hmAG1                                                                                                            This work                  N/A

  Plasmid: MaRX Ivf Hygromycin-Cdt1-mKO2                                                                                                   This work                  N/A

  Plasmid: pLB(N)CX-hGmnn-mAG1                                                                                                             This work                  N/A

  Plasmid: pTRIPZ-shSCRAMBLE                                                                                                               M. Pagano (NYU)            N/A

  Plasmid: pTRIPZ-EMI1-FLAG-Puro                                                                                                           M. Pagano (NYU)            N/A

  Plasmid: pcDNA3.1+Sin3B-FLAG                                                                                                             This work                  N/A

  Plasmid: pcDNA3.1+Sin3BDHID-FLAG                                                                                                         This work                  N/A

  Plasmid: pcDNA3.1+Sin3B (1--304)-FLAG                                                                                                    This work                  N/A

  Plasmid: pcDNA3.1+Sin3B (1--510)-FLAG                                                                                                    This work                  N/A

  Plasmid: pcDNA3.1+Sin3B (305--1098)-FLAG                                                                                                 This work                  N/A

  Plasmid: pcDNA3.1+Sin3B (511--1098)-FLAG                                                                                                 This work                  N/A

  Plasmid: pBabe-Lin37-V5-Hygro                                                                                                            ([@R32])                   N/A

  Plasmid: pEF6-Lin9-V5-His                                                                                                                ([@R32])                   N/A

  Plasmid: pEF6-Lin37-V5-His                                                                                                               ([@R32])                   N/A

  Plasmid: pcDNA3.1+ Bmyb-V5                                                                                                               ([@R32])                   N/A

  Plasmid: pCMV-p107-HA                                                                                                                    ([@R32])                   N/A

  Plasmid: pcDNA3.1+p130-HA                                                                                                                ([@R32])                   N/A

  Plasmid: Myc-FoxM1                                                                                                                       P. Raychaudhuri (UIC)      N/A

                                                                                                                                                                      

  Software and Algorithms                                                                                                                                             

                                                                                                                                                                      

  CRISPR Design                                                                                                                            Feng Zhang                 <http://crispr.mit.edu/>

  FastQC                                                                                                                                   Simon Andrews              [https://www.bioinformatics.babrahamac.uk/projects/fastqc/](http://https://www.bioinformatics.babrahamac.uk/projects/fastqc/)

  Trimmomatic                                                                                                                              ([@R7])                    <http://www.usadellab.org/cms/?page=trimmomatic>

  TopHat                                                                                                                                   ([@R55])                   <https://ccb.jhu.edu/software/tophat/index.shtml>

  HTSeq-count                                                                                                                              ([@R1])                    <https://htseq.readthedocs.io/en/release_0.10.0/>

  edgeR                                                                                                                                    ([@R43])                   <https://bioconductor.org/packages/release/bioc/html/edgeR.html>

  GSEA                                                                                                                                     ([@R53])                   <http://software.broadinstitute.org/gsea/index.jsp>

  Enrichr                                                                                                                                  ([@R9])                    <http://amp.pharm.mssm.edu/Enrichr/>

  Sequest                                                                                                                                  ([@R16])                   <http://fields.scripps.edu/yates/wp/?page_id=17>

  Prism                                                                                                                                    GraphPad Software          <https://www.graphpad.com/scientific-software/prism/>

  FloJo                                                                                                                                    FloJo, LLC                 <https://www.fiowio.com/>
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### Highlights

-   The chromatin modifier Sin3B interacts with the DREAM complex

-   Sin3B is required for the repression of DREAM target genes in quiescence

-   Sin3B inactivation allows quiescent cells to enter S phase upon APC/C^CDH1^ inhibition
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